Oxidative stress biomarkers in pediatric medicine - A 2013 update

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

A large body of circumstantial evidence emphasizes the critical role of reactive oxygen species (ROS), including superoxide anion and nitric oxide (NO), in acute and chronic pediatric diseases. About 15 years ago, measurement of oxidative damage affecting tissues and organs using specific biomarkers was introduced into the field of pediatric medicine. This chapter is intended to describe recent progress in clinical application of oxidative stress biomarkers in pediatric medicine. First, this chapter briefly presents the biochemistry and pathophysiology of ROS and antioxidative defense systems. Second, it discusses the interrelationship of endothelial dysfunction, NO system blockade, and oxidative stress. Third, it presents a list of clinically applicable biomarkers, along with pediatric diseases in which enhanced oxidative stress might be involved. The discussion emphasizes that many good biomarkers are readily measurable using enzyme-linked immunosorbent assay. Fourth, this chapter presents age-related reference normal ranges of oxidative stress biomarkers, including urinary acrolein-lysine, 8-hydroxy-2′-deoxyguanosine, nitrite/nitrate, and pentosidine. Furthermore, our new and interesting data related to oxidative stress and antioxidative defenses in congenital metabolic disorders, such as Wilson disease, urea cycle defects, citrin deficiency, and phenylketonuria, are presented. Rapid diagnostic tests for measuring blood levels of total hydroperoxides and biological antioxidative potential and urinary levels of 8-hydroxy-2′-deoxyguanosine are also explained. Finally, this chapter describes recent clinical studies that have evaluated the efficacy of antioxidative intervention for oxidative-stress-related diseases. Repeated measurement of multiple appropriate parameters will enable us to discern the pathophysiological patterns of pediatric diseases and guide our therapies appropriately.

Original languageEnglish
Title of host publicationSystems Biology of Free Radicals and Antioxidants
PublisherSpringer-Verlag Berlin Heidelberg
Pages689-715
Number of pages27
ISBN (Print)9783642300189, 3642300170, 9783642300172
DOIs
Publication statusPublished - May 1 2012

Fingerprint

Oxidative Stress
Biomarkers
Medicine
Pediatrics
Reactive Oxygen Species
Nitric Oxide
Reference Values
Acrolein
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Hepatolenticular Degeneration
Phenylketonurias
Nitrites
Routine Diagnostic Tests
Superoxides
Biochemistry
Nitrates
Hydrogen Peroxide
Lysine
Urea
Chronic Disease

Keywords

  • Antioxidants
  • Biomarkers
  • Enzyme-linked immunosorbent assay
  • Nitric oxide
  • Oxidative stress
  • Pediatric medicine
  • Rapid diagnostic testing
  • Reactive oxygen species

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Tsukahara, H. (2012). Oxidative stress biomarkers in pediatric medicine - A 2013 update. In Systems Biology of Free Radicals and Antioxidants (pp. 689-715). Springer-Verlag Berlin Heidelberg. https://doi.org/10.1007/978-3-642-30018-9_36

Oxidative stress biomarkers in pediatric medicine - A 2013 update. / Tsukahara, Hirokazu.

Systems Biology of Free Radicals and Antioxidants. Springer-Verlag Berlin Heidelberg, 2012. p. 689-715.

Research output: Chapter in Book/Report/Conference proceedingChapter

Tsukahara, H 2012, Oxidative stress biomarkers in pediatric medicine - A 2013 update. in Systems Biology of Free Radicals and Antioxidants. Springer-Verlag Berlin Heidelberg, pp. 689-715. https://doi.org/10.1007/978-3-642-30018-9_36
Tsukahara H. Oxidative stress biomarkers in pediatric medicine - A 2013 update. In Systems Biology of Free Radicals and Antioxidants. Springer-Verlag Berlin Heidelberg. 2012. p. 689-715 https://doi.org/10.1007/978-3-642-30018-9_36
Tsukahara, Hirokazu. / Oxidative stress biomarkers in pediatric medicine - A 2013 update. Systems Biology of Free Radicals and Antioxidants. Springer-Verlag Berlin Heidelberg, 2012. pp. 689-715
@inbook{c45dbbe3b4b54a919736d3a2ae8404fe,
title = "Oxidative stress biomarkers in pediatric medicine - A 2013 update",
abstract = "A large body of circumstantial evidence emphasizes the critical role of reactive oxygen species (ROS), including superoxide anion and nitric oxide (NO), in acute and chronic pediatric diseases. About 15 years ago, measurement of oxidative damage affecting tissues and organs using specific biomarkers was introduced into the field of pediatric medicine. This chapter is intended to describe recent progress in clinical application of oxidative stress biomarkers in pediatric medicine. First, this chapter briefly presents the biochemistry and pathophysiology of ROS and antioxidative defense systems. Second, it discusses the interrelationship of endothelial dysfunction, NO system blockade, and oxidative stress. Third, it presents a list of clinically applicable biomarkers, along with pediatric diseases in which enhanced oxidative stress might be involved. The discussion emphasizes that many good biomarkers are readily measurable using enzyme-linked immunosorbent assay. Fourth, this chapter presents age-related reference normal ranges of oxidative stress biomarkers, including urinary acrolein-lysine, 8-hydroxy-2′-deoxyguanosine, nitrite/nitrate, and pentosidine. Furthermore, our new and interesting data related to oxidative stress and antioxidative defenses in congenital metabolic disorders, such as Wilson disease, urea cycle defects, citrin deficiency, and phenylketonuria, are presented. Rapid diagnostic tests for measuring blood levels of total hydroperoxides and biological antioxidative potential and urinary levels of 8-hydroxy-2′-deoxyguanosine are also explained. Finally, this chapter describes recent clinical studies that have evaluated the efficacy of antioxidative intervention for oxidative-stress-related diseases. Repeated measurement of multiple appropriate parameters will enable us to discern the pathophysiological patterns of pediatric diseases and guide our therapies appropriately.",
keywords = "Antioxidants, Biomarkers, Enzyme-linked immunosorbent assay, Nitric oxide, Oxidative stress, Pediatric medicine, Rapid diagnostic testing, Reactive oxygen species",
author = "Hirokazu Tsukahara",
year = "2012",
month = "5",
day = "1",
doi = "10.1007/978-3-642-30018-9_36",
language = "English",
isbn = "9783642300189",
pages = "689--715",
booktitle = "Systems Biology of Free Radicals and Antioxidants",
publisher = "Springer-Verlag Berlin Heidelberg",

}

TY - CHAP

T1 - Oxidative stress biomarkers in pediatric medicine - A 2013 update

AU - Tsukahara, Hirokazu

PY - 2012/5/1

Y1 - 2012/5/1

N2 - A large body of circumstantial evidence emphasizes the critical role of reactive oxygen species (ROS), including superoxide anion and nitric oxide (NO), in acute and chronic pediatric diseases. About 15 years ago, measurement of oxidative damage affecting tissues and organs using specific biomarkers was introduced into the field of pediatric medicine. This chapter is intended to describe recent progress in clinical application of oxidative stress biomarkers in pediatric medicine. First, this chapter briefly presents the biochemistry and pathophysiology of ROS and antioxidative defense systems. Second, it discusses the interrelationship of endothelial dysfunction, NO system blockade, and oxidative stress. Third, it presents a list of clinically applicable biomarkers, along with pediatric diseases in which enhanced oxidative stress might be involved. The discussion emphasizes that many good biomarkers are readily measurable using enzyme-linked immunosorbent assay. Fourth, this chapter presents age-related reference normal ranges of oxidative stress biomarkers, including urinary acrolein-lysine, 8-hydroxy-2′-deoxyguanosine, nitrite/nitrate, and pentosidine. Furthermore, our new and interesting data related to oxidative stress and antioxidative defenses in congenital metabolic disorders, such as Wilson disease, urea cycle defects, citrin deficiency, and phenylketonuria, are presented. Rapid diagnostic tests for measuring blood levels of total hydroperoxides and biological antioxidative potential and urinary levels of 8-hydroxy-2′-deoxyguanosine are also explained. Finally, this chapter describes recent clinical studies that have evaluated the efficacy of antioxidative intervention for oxidative-stress-related diseases. Repeated measurement of multiple appropriate parameters will enable us to discern the pathophysiological patterns of pediatric diseases and guide our therapies appropriately.

AB - A large body of circumstantial evidence emphasizes the critical role of reactive oxygen species (ROS), including superoxide anion and nitric oxide (NO), in acute and chronic pediatric diseases. About 15 years ago, measurement of oxidative damage affecting tissues and organs using specific biomarkers was introduced into the field of pediatric medicine. This chapter is intended to describe recent progress in clinical application of oxidative stress biomarkers in pediatric medicine. First, this chapter briefly presents the biochemistry and pathophysiology of ROS and antioxidative defense systems. Second, it discusses the interrelationship of endothelial dysfunction, NO system blockade, and oxidative stress. Third, it presents a list of clinically applicable biomarkers, along with pediatric diseases in which enhanced oxidative stress might be involved. The discussion emphasizes that many good biomarkers are readily measurable using enzyme-linked immunosorbent assay. Fourth, this chapter presents age-related reference normal ranges of oxidative stress biomarkers, including urinary acrolein-lysine, 8-hydroxy-2′-deoxyguanosine, nitrite/nitrate, and pentosidine. Furthermore, our new and interesting data related to oxidative stress and antioxidative defenses in congenital metabolic disorders, such as Wilson disease, urea cycle defects, citrin deficiency, and phenylketonuria, are presented. Rapid diagnostic tests for measuring blood levels of total hydroperoxides and biological antioxidative potential and urinary levels of 8-hydroxy-2′-deoxyguanosine are also explained. Finally, this chapter describes recent clinical studies that have evaluated the efficacy of antioxidative intervention for oxidative-stress-related diseases. Repeated measurement of multiple appropriate parameters will enable us to discern the pathophysiological patterns of pediatric diseases and guide our therapies appropriately.

KW - Antioxidants

KW - Biomarkers

KW - Enzyme-linked immunosorbent assay

KW - Nitric oxide

KW - Oxidative stress

KW - Pediatric medicine

KW - Rapid diagnostic testing

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=84929136418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929136418&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-30018-9_36

DO - 10.1007/978-3-642-30018-9_36

M3 - Chapter

SN - 9783642300189

SN - 3642300170

SN - 9783642300172

SP - 689

EP - 715

BT - Systems Biology of Free Radicals and Antioxidants

PB - Springer-Verlag Berlin Heidelberg

ER -